Device Vascular

Worley Adv Coronary Sinus Guide

Payments companies reported to CMS as associated with Worley Adv Coronary Sinus Guide. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.

$4.5Massociated payments (2023-2025)
27clinicians with associated payments
1company reporting

By year

2023 $1.6M
2024 $1.4M
2025 $1.5M

Payments reported as associated with Worley Adv Coronary Sinus Guide, per program year, as reported to CMS.

Who makes it

Specialties most often involved

Cardiovascular Disease $2.8M
Clinical Cardiac Electrophysiology $1.6M
Pediatric Cardiology $156
Interventional Cardiology $137
Internal Medicine $75.86

Where the associated payments went, by the receiving clinician's specialty.

Clinicians most associated with Worley Adv Coronary Sinus Guide

These are the largest totals companies reported as associated with Worley Adv Coronary Sinus Guide. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.

ClinicianLocationSpecialtyAssociated payments (2023-2025)
Paul Kurth Santa Barbara, CA Cardiovascular Disease $2,849,244.53
Seth Worley Lancaster, PA Clinical Cardiac Electrophysiology $1,596,318.62
Matthew Mckillop Jacksonville, FL Clinical Cardiac Electrophysiology $15,741.73
Alexi Zemsky Portland, OR Clinical Cardiac Electrophysiology $3,840.00
Mark Marieb Hamden, CT Clinical Cardiac Electrophysiology $2,640.00
Johannes Von Alvensleben Aurora, CO Pediatric Cardiology $137.23
Matthew Zipse Aurora, CO Interventional Cardiology $137.22
Matthew Sellers Greenville, SC Clinical Cardiac Electrophysiology $131.98
Jeffrey Senfield Greenville, SC Clinical Cardiac Electrophysiology $131.98
Anca Chiriac Jacksonville, FL Cardiovascular Disease $113.93

Prescribed Worley Adv Coronary Sinus Guide?

See what its makers reported for your doctor. Two steps, private, no account.

Check my doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.